4 Midcap Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch for Future Multibagger Potential: Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis

Latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis meet that test, with market caps from Rs 49,108 crore to Rs 86,261 crore and Max Healthcare offering the largest market cap at Rs 86,261 crore. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and latest quarter revenue growth between 10 and 20 per cent over the same quarter a year earlier, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and latest quarter revenue growth between 10 and 20 per cent over the same quarter a year earlier, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening latest quarter revenue growth 10-20 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 27 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Latest Quarter Revenue Growth 10-20 Per Cent Stocks and Why Do They Attract Multibagger Interest?

Latest quarter revenue growth 10-20 per cent stocks are shares of mid sized companies whose sales in the latest quarter grew 10 to 20 per cent over the same quarter last year, a sign that demand for their products is holding up well. The four here cover hospitals, household products, malls and IT services.

Quarterly sales growth in this range, backed by rising full-year profit, shows demand that is growing without any strain on the business. Within latest quarter revenue growth 10-20 per cent stocks, the four companies show rising profit. For latest quarter revenue growth 10-20 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read latest quarter revenue growth 10-20 per cent stocks, the common thread is rising profit backed by complete financial data. With latest quarter revenue growth 10-20 per cent stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for latest quarter revenue growth 10-20 per cent stocks are complete. Read each company’s latest results and exchange filings before acting on latest quarter revenue growth 10-20 per cent stocks.

Latest Quarter Revenue Growth 10-20 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 27 October 2026. Mphasis combines the lowest PE of the group, 25.71, with the highest return on equity, 17.34%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Max Healthcare Institute	845	86,261	59.20	60.75	13.42%	0.32	815.00 to 1,221.90
Godrej Consumer Products	828.80	84,348	44.08	34.40	14.71%	0.35	828.80 to 1,273.90
Phoenix Mills	1,905	68,990	42.32	31.56	11.14%	0.48	1,465.60 to 2,169.80
Mphasis	2,618.40	49,108	25.71	18.49	17.34%	0.24	2,013.00 to 2,975.00

Max Healthcare: 24.26% Profit CAGR Since FY22

Max Healthcare Institute runs a network of multi-speciality hospitals in Delhi NCR, Mumbai and other cities. It reported FY26 revenue of Rs 8,536.07 crore, up 18.82% year on year, and net profit of Rs 1,442.41 crore, up 34.07%. Net profit has compounded at 24.26% a year since FY22, while revenue has grown 20.42% a year. Operating margin was 28.15% in FY26. The debt-to-equity ratio is 0.32.

In the June 2026 quarter, revenue rose 16.60% to Rs 2,406.69 crore and net profit grew 4.87% to Rs 322.96 crore. The share price has gained 149.91% over five years. Domestic institutions raised their holding from 17.42% in June 2025 to 29.96% in June 2026. The stock trades at a PE of 59.20 against an industry PE of 60.75, below the sector average, with a return on equity of 13.42%.

Godrej Consumer: Profit Compounding at 1.08% a Year

Godrej Consumer Products sells household insecticides, soaps, hair colour and personal care brands in India, Africa and Asia. It reported FY26 revenue of Rs 15,444.07 crore, up 7.90% year on year, and net profit of Rs 1,861.47 crore, up 0.50%. Revenue has compounded at 5.71% a year since FY22. Operating margin was 19.45% in FY26. The debt-to-equity ratio is 0.35.

The stock trades at a PE of 44.08 against an industry PE of 34.40, with a return on equity of 14.71%. The dividend yield is 2.43%. In the June 2026 quarter, revenue rose 14.17% to Rs 4,277.35 crore and net profit grew 11.51% to Rs 504.52 crore. Domestic institutions raised their holding from 12.40% in June 2025 to 19.59% in June 2026.

Phoenix Mills: 58.28% Profit CAGR Since FY22

Phoenix Mills owns and runs large retail malls across India under the Phoenix Marketcity and Palladium brands, along with offices, hotels and residences. It reported FY26 revenue of Rs 4,593.55 crore, up 15.87% year on year, and net profit of Rs 1,556.61 crore, up 19.60%. Net profit has compounded at 58.28% a year since FY22, while revenue has grown 31.04% a year. Operating margin was 62.83% in FY26. The debt-to-equity ratio is 0.48.

In the June 2026 quarter, revenue rose 13.27% to Rs 1,115.15 crore and net profit grew 23.02% to Rs 393.55 crore. The share price has gained 303.49% over five years and 11.92% over the past year. Domestic institutions raised their holding from 15.47% in September 2025 to 17.31% in September 2026. The stock trades at a PE of 42.32 against an industry PE of 31.56.

Mphasis: Profit Compounding at 6.81% a Year

Mphasis provides IT, cloud and application services to banking, insurance and technology clients. It reported FY26 revenue of Rs 16,205.54 crore, up 11.88% year on year, and net profit of Rs 1,862.60 crore, up 9.43%. Net profit has compounded at 6.81% a year since FY22, while revenue has grown 7.53% a year. Operating margin was 20.58% in FY26. The debt-to-equity ratio is 0.24.

The stock trades at a PE of 25.71 against an industry PE of 18.49, with a return on equity of 17.34%. The dividend yield is 2.41%. In the June 2026 quarter, revenue rose 17.14% to Rs 4,466.91 crore and net profit grew 10.82% to Rs 489.51 crore. Domestic institutions raised their holding from 37.07% in September 2025 to 45.85% in September 2026.

Latest Quarter Revenue Growth 10-20 Per Cent Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these latest quarter revenue growth 10-20 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR	Operating Margin (Latest Quarter)
Max Healthcare	8,536.07	1,442.41	18.82%	20.42%	24.26%	27.00%
Godrej Consumer	15,444.07	1,861.47	7.90%	5.71%	1.08%	19.89%
Phoenix Mills	4,593.55	1,556.61	15.87%	31.04%	58.28%	63.42%
Mphasis	16,205.54	1,862.60	11.88%	7.53%	6.81%	20.04%

Check the Univest Screener for live data on these latest quarter revenue growth 10-20 per cent stocks

Institutional Holding in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis

Institutional holding shows who is backing these latest quarter revenue growth 10-20 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Max Healthcare has the deepest institutional backing, with FII and DII together holding 71.74% as of June 2026. Domestic institutions increased their holding over the past year in Max Healthcare (from 17.42% to 29.96%), Godrej Consumer (from 12.40% to 19.59%), Phoenix Mills (from 15.47% to 17.31%) and Mphasis (from 37.07% to 45.85%).

Stock	Promoter	FII	DII	Public	Quarter
Max Healthcare	23.71%	41.78%	29.96%	4.56%	June 2026
Godrej Consumer	53.05%	12.33%	19.59%	15.03%	June 2026
Phoenix Mills	47.24%	31.62%	17.31%	3.83%	September 2026
Mphasis	30.53%	19.39%	45.85%	4.23%	September 2026

Risks to Weigh in Latest Quarter Revenue Growth 10-20 Per Cent Stocks

Being careful with latest quarter revenue growth 10-20 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Latest Quarter Revenue Growth 10-20 Per Cent Stocks

Picking from latest quarter revenue growth 10-20 per cent stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (18.49 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis live prices.

Conclusion

Among latest quarter revenue growth 10-20 per cent stocks, Max Healthcare stands out for the largest market cap at Rs 86,261 crore, Godrej Consumer for 7.90% revenue growth in FY26, Phoenix Mills for the fastest profit growth, 58.28% a year since FY22 and Mphasis for the highest return on equity at 17.34%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing latest quarter revenue growth 10-20 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Latest Quarter Revenue Growth 10-20 Per Cent Stocks to Watch

Which are the best latest quarter revenue growth 10-20 per cent stocks to watch for multibagger potential?

Ans. Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis are the 4 names this list highlights, with market caps of Rs 86,261 crore, Rs 84,348 crore, Rs 68,990 crore and Rs 49,108 crore respectively. Max Healthcare is notable for the largest market cap at Rs 86,261 crore. Godrej Consumer stands out for 7.90% revenue growth in FY26. Phoenix Mills offers the fastest profit growth, 58.28% a year since FY22. Mphasis brings the highest return on equity at 17.34%. These are watchlist names for latest quarter revenue growth 10-20 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Mphasis a good stock for long-term investors?

Ans. Mphasis has a return on equity of 17.34%, a PE of 25.71 against an industry PE of 18.49 and a market cap of Rs 49,108 crore. Net profit has compounded at 6.81% a year since FY22, and FY26 revenue rose 11.88% while June 2026 quarter net profit grew 10.82%. Long-term returns in latest quarter revenue growth 10-20 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Phoenix Mills become a multibagger from here?

Ans. Phoenix Mills has already gained 303.49% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in latest quarter revenue growth 10-20 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 58.28% a year since FY22, and FY26 revenue rose 15.87%. At a PE of 42.32 against an industry PE of 31.56, valuation should be checked against that growth before investing.

What is the market cap of Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?

Ans. As of 27 October 2026, Max Healthcare has a market cap of Rs 86,261 crore, Godrej Consumer has a market cap of Rs 84,348 crore, Phoenix Mills has a market cap of Rs 68,990 crore and Mphasis has a market cap of Rs 49,108 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on latest quarter revenue growth 10-20 per cent stocks.

What are the risks of investing in latest quarter revenue growth 10-20 per cent stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Mphasis trades at a PE of 25.71 against an industry PE of 18.49, so earnings growth needs to hold up.

Why is Mphasis trading at a PE of 25.71?

Ans. Mphasis’ PE of 25.71 compares with an industry PE of 18.49. The market is paying a premium for a return on equity of 17.34% and latest-quarter profit growth of 10.82%, which also means the stock is more sensitive if growth slows. Investors in latest quarter revenue growth 10-20 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Max Healthcare, Godrej Consumer, Phoenix Mills and Mphasis?

Ans. As of the latest reported quarter, FII and DII together hold 71.74% of Max Healthcare (41.78% and 29.96%), 31.92% of Godrej Consumer (12.33% and 19.59%), 48.93% of Phoenix Mills (31.62% and 17.31%) and 65.24% of Mphasis (19.39% and 45.85%). Rising institutional holding is a useful signal in latest quarter revenue growth 10-20 per cent stocks, though it should be read with earnings trends rather than on its own.